Several splicing factors have been implicated in cancer, including SF3B1, U2AF1, and SRSF2. These factors are responsible for recognizing and binding to specific sequences on pre-mRNA to facilitate splicing. Mutations or altered expression of these factors can lead to improper splicing events, which may result in the production of oncogenic protein isoforms or the loss of tumor suppressor proteins.
